Argos Therapeutics Inc (ARGS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
31 Pages - GLDATA62489
$250.00

Summary

Argos Therapeutics Inc (Argos) is a biopharmaceutical company that develops and commercializes immunotherapies for the treatment of infectious diseases and cancer. The company develops a pipeline of products based on its proprietary Arcelis technology platform. Its Arcelis-based immunotherapies use the patient’s dendritic cells to activate an immune response specific to the patient’s disease. Argos products include AGS-003 for the treatment of metastatic renal cell carcinoma, or mRCC, and AGS-004 for the treatment of HIV. The company use biology of dendritic cells to develop novel technologies with applications for organ and tissue transplantation and inflammatory and the treatment of autoimmune disorders. Argos is headquartered in Durham, North Carolina, the US.

Argos Therapeutics Inc (ARGS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Argos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Argos Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Argos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Argos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Argos Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9
Argos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Argos Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Argos Therapeutics Raises US$60 Million In Series E Financing 12
Argos Therapeutics Raises US$16 Million In Venture Financing 14
Argos Therapeutics Raises US$25 Million In Series D Financing 15
Partnerships 16
Argos Therapeutics Enters into Research Agreement with Personalis 16
Licensing Agreements 17
Argos Therapeutics Enters into Licensing Agreement with Lummy HK 17
Equity Offering 18
Argos Therapeutics Prices Public Offering of Shares and Warrants for USD50 Million 18
Argos Therapeutics Plans to Raise up to USD124 Million in Public Offering of Shares 20
Argos Therapeutics Raises USD29.8 Million in Second Tranche of Private Placement of Shares and Warrants 21
Argos Therapeutics Plans to Raise up to USD36 Million in Public Offering of Shares 22
Argos Therapeutics Raises USD20 Million in First Tranche Private Placement of Shares and Warrants 23
Argos Therapeutics Completes Ipo For Us$45 Million 25
Argos Therapeutics Inc - Key Competitors 28
Key Employees 29
Locations And Subsidiaries 30
Head Office 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Argos Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Argos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Argos Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Argos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Argos Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Argos Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9
Argos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Argos Therapeutics Raises US$60 Million In Series E Financing 12
Argos Therapeutics Raises US$16 Million In Venture Financing 14
Argos Therapeutics Raises US$25 Million In Series D Financing 15
Argos Therapeutics Enters into Research Agreement with Personalis 16
Argos Therapeutics Enters into Licensing Agreement with Lummy HK 17
Argos Therapeutics Prices Public Offering of Shares and Warrants for USD50 Million 18
Argos Therapeutics Plans to Raise up to USD124 Million in Public Offering of Shares 20
Argos Therapeutics Raises USD29.8 Million in Second Tranche of Private Placement of Shares and Warrants 21
Argos Therapeutics Plans to Raise up to USD36 Million in Public Offering of Shares 22
Argos Therapeutics Raises USD20 Million in First Tranche Private Placement of Shares and Warrants 23
Argos Therapeutics Completes Ipo For Us$45 Million 25
Argos Therapeutics Inc, Key Competitors 28
Argos Therapeutics Inc, Key Employees 29

List of Figures
Argos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Argos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Argos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Argos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Argos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Argos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Argos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Argos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Argos Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838